Other
MYRISTAMIDE DEA
Safety score · 0–100
Moderate
Derived from EU CosIng regulatory status, PubChem hazard data and published research. How we score.
About
A myristic acid diethanolamide foam modifier used in surfactant systems, subject to EU Annex III restriction (III/60) due to DEA-related nitrosamine concerns.
Myristamide DEA is the diethanolamide of myristic acid (tetradecanoic acid), used as a foam booster and viscosity modifier in cleansing formulations. Like all DEA fatty acid amides, it falls under EU CosIng Annex III reference III/60, which restricts DEA derivatives due to the risk of NDELA formation. Compliance requires that the ingredient be free of secondary amines as impurities, formulations must not contain nitrosating agents, and it should be used in accordance with purity specifications. Similar restrictions apply in the US under CIR recommendations.
Skin benefits
- Foam boosting and stabilization
- Viscosity control in liquid formulations
- Skin conditioning agent
Known concerns
- EU Annex III restricted (III/60) — NDELA nitrosamine formation risk
- Must not be combined with nitrosating agents
- Residual free DEA is a sensitization concern
- Purity requirements must be met
References
EU CosIng database
European Commission cosmetic ingredient registry — regulatory status, restrictions, authorised functions.
Related others
Check your shelf
Find MYRISTAMIDE DEA in your products.
Scan any cosmetic product with LuxSense to see if it contains MYRISTAMIDE DEA and get a full ingredient breakdown with safety scores.
This profile is for educational purposes and does not constitute medical advice. Regulatory status and scientific understanding evolve — always read the physical product label and consult a healthcare professional for personal concerns.